Advanced search
Publication Cover
Cancer Investigation Volume 28, 2010 - Issue 6
Submit an article Journal homepage
185
Views
13
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLECellular and Molecular Biology

Synergistic Effect of Celecoxib on TRAIL-induced Apoptosis in Hepatocellular Carcinoma Cells

Guoyue LuDepartment of General Surgery, The First Clinical Hospital, Jilin University, 71 Xinmin Street, Changchun, Jilin 130021, People's Republic of China,Correspondence[email protected]
,
Yahui LiuDepartment of General Surgery, The First Clinical Hospital, Jilin University, 71 Xinmin Street, Changchun, Jilin 130021, People's Republic of China,
,
Bai JiDepartment of General Surgery, The First Clinical Hospital, Jilin University, 71 Xinmin Street, Changchun, Jilin 130021, People's Republic of China,
,
Feng WeiDepartment of General Surgery, The First Clinical Hospital, Jilin University, 71 Xinmin Street, Changchun, Jilin 130021, People's Republic of China,
,
Chunhai HaoDepartment of Pathology & Laboratory Medicine, Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia, USA
&
Guangyi WangDepartment of General Surgery, The First Clinical Hospital, Jilin University, 71 Xinmin Street, Changchun, Jilin 130021, People's Republic of China,
Pages 629-634 | Published online: 15 Apr 2010

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Liu Hong, Shujun Li, Yu Han, Jianjun Du, Hongwei Zhang, Jipeng Li, Qingchuan Zhao, Kaichun Wu & Daiming Fan. (2011) Angiogenesis-related molecular targets in esophageal cancer. Expert Opinion on Investigational Drugs 20:5, pages 637-644.
Read now

Articles from other publishers (12)

Wei Jiang, Dong-Bo Wu, Si-Yu Fu, En-Qiang Chen, Hong Tang & Tao-You Zhou. (2019) Insight into the role of TRAIL in liver diseases. Biomedicine & Pharmacotherapy 110, pages 641-645.
Crossref
Silvia von Karstedt, Antonella Montinaro & Henning Walczak. (2017) Exploring the TRAILs less travelled: TRAIL in cancer biology and therapy. Nature Reviews Cancer 17:6, pages 352-366.
Crossref
Jichun SunXiao YuChangfa WangCan YuZhiqiang LiWanpin NieXundi XuXiongying MiaoXiaoxin Jin. (2017) RIP-1/c-FLIPL Induce Hepatic Cancer Cell Apoptosis Through Regulating Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL). Medical Science Monitor 23, pages 1190-1199.
Crossref
Mei-Chuan Chen, Hui-Hsuan Huang, Chin-Yu Lai, Yi-Jyun Lin, Jing-Ping Liou, Mei-Jung Lai, Yu-Hsuan Li, Che-Ming Teng & Chia-Ron Yang. (2015) Novel histone deacetylase inhibitor MPT0G009 induces cell apoptosis and synergistic anticancer activity with tumor necrosis factor-related apoptosis-inducing ligand against human hepatocellular carcinoma. Oncotarget 7:1, pages 402-417.
Crossref
H-H Cheng, C-T Chou, Y-C Lu, T Lu, C-C Chi, L-L Tseng, S-I Liu, J-S Cheng, C-C Kuo, W-Z Liang & C-R Jan. (2014) Celecoxib-induced increase in cytosolic Ca 2+ levels and apoptosis in HA59T human hepatoma cells . Human & Experimental Toxicology 33:11, pages 1089-1098.
Crossref
GONG LIU, MING-YANG YU, XU HUANG, DONG ZHU, SHIHUAN CHENG, RENSHI MA & GUISHAN GU. (2014) Synergistic effect of celecoxib in tumor necrosis factor-related apoptosis-inducing ligand treatment in osteosarcoma cells. Molecular Medicine Reports 10:4, pages 2198-2202.
Crossref
Sundas Fayyaz, Ilhan Yaylim, Saime Turan, Sobia Kanwal & Ammad Ahmad Farooqi. (2014) Hepatocellular carcinoma: targeting of oncogenic signaling networks in TRAIL resistant cancer cells. Molecular Biology Reports 41:10, pages 6909-6917.
Crossref
Mi-Ju Kim, Kyung-Soo Hong, Hak-Bong Kim, Su-Hoon Lee, Jae-Ho Bae, Dong-Wan Kim, Trong Tuan Dao, Won Keun Oh, Chi-Dug Kang & Sun-Hee Kim. (2013) Ku70 acetylation and modulation of c-Myc/ATF4/CHOP signaling axis by SIRT1 inhibition lead to sensitization of HepG2 cells to TRAIL through induction of DR5 and down-regulation of c-FLIP. The International Journal of Biochemistry & Cell Biology 45:3, pages 711-723.
Crossref
Eun Young Kim, Ji Sun Yu, Mihi Yang & An Keun Kim. (2012) Sub-toxic dose of apigenin sensitizes HepG2 cells to TRAIL through ERK-dependent up-regulation of TRAIL receptor DR5. Molecules and Cells 35:1, pages 32-40.
Crossref
Venturina Stagni, Simonetta Santini & Daniela Barilà. (2012) A New Player in the Development of TRAIL Based Therapies for Hepatocarcinoma Treatment: ATM Kinase. Cancers 4:2, pages 354-378.
Crossref
Bingfei Dong, Guoyue Lv, Quan Wang & Guangyi Wang. (2012) Targeting A20 enhances TRAIL-induced apoptosis in hepatocellular carcinoma cells. Biochemical and Biophysical Research Communications 418:2, pages 433-438.
Crossref
Ahmad R. Safa & Karen E. Pollok. (2011) Targeting the Anti-Apoptotic Protein c-FLIP for Cancer Therapy. Cancers 3:2, pages 1639-1671.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.